annual CFI:
-$420.07M-$323.92M(-336.87%)Summary
- As of today (May 31, 2025), ARWR annual cash flow from investing activities is -$420.07 million, with the most recent change of -$323.92 million (-336.87%) on September 30, 2024.
- During the last 3 years, ARWR annual CFI has fallen by -$278.39 million (-196.50%).
- ARWR annual CFI is now -3074.85% below its all-time high of $14.12 million, reached on September 30, 2015.
Performance
ARWR Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$420.21M-$497.12M(-646.37%)Summary
- As of today (May 31, 2025), ARWR quarterly cash flow from investing activities is -$420.21 million, with the most recent change of -$497.12 million (-646.37%) on March 31, 2025.
- Over the past year, ARWR quarterly CFI has dropped by -$151.28 million (-56.25%).
- ARWR quarterly CFI is now -646.37% below its all-time high of $76.91 million, reached on December 31, 2024.
Performance
ARWR quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$559.28M-$151.28M(-37.08%)Summary
- As of today (May 31, 2025), ARWR TTM cash flow from investing activities is -$559.28 million, with the most recent change of -$151.28 million (-37.08%) on March 31, 2025.
- Over the past year, ARWR TTM CFI has dropped by -$375.78 million (-204.79%).
- ARWR TTM CFI is now -1232.64% below its all-time high of $49.38 million, reached on December 31, 2023.
Performance
ARWR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ARWR Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -336.9% | -56.3% | -204.8% |
| 3 y3 years | -196.5% | -502.4% | -132.1% |
| 5 y5 years | -779.8% | -135.9% | -306.4% |
ARWR Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7654.7% | at low | -646.4% | at low | -1232.6% | at low |
| 5 y | 5-year | -7654.7% | at low | -646.4% | at low | -1232.6% | at low |
| alltime | all time | -3074.8% | at low | -646.4% | at low | -1232.6% | at low |
ARWR Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$420.21M(-646.4%) | -$559.28M(+37.1%) |
| Dec 2024 | - | $76.91M(-134.5%) | -$408.00M(-2.9%) |
| Sep 2024 | -$420.07M(+336.9%) | -$222.92M(-3308.0%) | -$420.07M(+152.1%) |
| Jun 2024 | - | $6.95M(-102.6%) | -$166.64M(-9.2%) |
| Mar 2024 | - | -$268.94M(-514.8%) | -$183.49M(-471.6%) |
| Dec 2023 | - | $64.84M(+112.5%) | $49.38M(-151.4%) |
| Sep 2023 | -$96.16M(+1675.1%) | $30.51M(-408.0%) | -$96.16M(+6.6%) |
| Jun 2023 | - | -$9.90M(-72.5%) | -$90.22M(+373.9%) |
| Mar 2023 | - | -$36.06M(-55.3%) | -$19.04M(-63.9%) |
| Dec 2022 | - | -$80.69M(-321.4%) | -$52.73M(+873.3%) |
| Sep 2022 | -$5.42M(-96.2%) | $36.45M(-40.5%) | -$5.42M(-96.6%) |
| Jun 2022 | - | $61.28M(-187.8%) | -$160.11M(-33.5%) |
| Mar 2022 | - | -$69.75M(+108.9%) | -$240.93M(+17.4%) |
| Dec 2021 | - | -$33.38M(-71.8%) | -$205.22M(+44.9%) |
| Sep 2021 | -$141.68M(-41.2%) | -$118.25M(+505.1%) | -$141.68M(+58.6%) |
| Jun 2021 | - | -$19.54M(-42.6%) | -$89.33M(+17.8%) |
| Mar 2021 | - | -$34.05M(-212.9%) | -$75.82M(-65.5%) |
| Dec 2020 | - | $30.16M(-145.8%) | -$219.90M(-8.7%) |
| Sep 2020 | -$240.78M(+404.3%) | -$65.89M(+992.1%) | -$240.78M(+52.3%) |
| Jun 2020 | - | -$6.03M(-96.6%) | -$158.05M(+14.8%) |
| Mar 2020 | - | -$178.13M(-2019.5%) | -$137.62M(-569.9%) |
| Dec 2019 | - | $9.28M(-44.9%) | $29.29M(-161.3%) |
| Sep 2019 | -$47.75M(+542.2%) | $16.83M(+16.9%) | -$47.75M(-22.1%) |
| Jun 2019 | - | $14.40M(-228.4%) | -$61.33M(-41.4%) |
| Mar 2019 | - | -$11.22M(-83.4%) | -$104.58M(+36.6%) |
| Dec 2018 | - | -$67.76M(-2186.7%) | -$76.55M(+929.6%) |
| Sep 2018 | -$7.43M(-84.7%) | $3.25M(-111.3%) | -$7.43M(-50.1%) |
| Jun 2018 | - | -$28.85M(-271.6%) | -$14.90M(-1549.9%) |
| Mar 2018 | - | $16.82M(+1139.2%) | $1.03M(-102.4%) |
| Dec 2017 | - | $1.36M(-132.2%) | -$41.99M(-13.7%) |
| Sep 2017 | -$48.64M(-461.7%) | -$4.22M(-67.4%) | -$48.64M(+5.4%) |
| Jun 2017 | - | -$12.93M(-50.7%) | -$46.14M(+94.3%) |
| Mar 2017 | - | -$26.20M(+394.7%) | -$23.75M(-527.4%) |
| Dec 2016 | - | -$5.30M(+209.3%) | $5.56M(-58.7%) |
| Sep 2016 | $13.45M(-4.8%) | -$1.71M(-118.1%) | $13.45M(-36.0%) |
| Jun 2016 | - | $9.46M(+204.6%) | $21.01M(+35.3%) |
| Mar 2016 | - | $3.11M(+19.8%) | $15.52M(-26.8%) |
| Dec 2015 | - | $2.59M(-55.6%) | $21.21M(+50.2%) |
| Sep 2015 | $14.12M(-138.7%) | $5.84M(+47.0%) | $14.12M(+10.1%) |
| Jun 2015 | - | $3.98M(-54.8%) | $12.82M(+31.1%) |
| Mar 2015 | - | $8.80M(-295.5%) | $9.78M(-137.9%) |
| Dec 2014 | - | -$4.50M(-199.0%) | -$25.84M(-29.2%) |
| Sep 2014 | -$36.48M(+283.2%) | $4.54M(+385.4%) | -$36.48M(-23.3%) |
| Jun 2014 | - | $936.40K(-103.5%) | -$47.55M(-9.8%) |
| Mar 2014 | - | -$26.82M(+77.1%) | -$52.74M(+112.9%) |
| Dec 2013 | - | -$15.15M(+132.3%) | -$24.78M(+160.3%) |
| Sep 2013 | -$9.52M(-2260.9%) | -$6.52M(+53.1%) | -$9.52M(+237.4%) |
| Jun 2013 | - | -$4.26M(-471.5%) | -$2.82M(-307.4%) |
| Mar 2013 | - | $1.15M(+923.4%) | $1.36M(>+9900.0%) |
| Dec 2012 | - | $112.00K(-37.2%) | $13.00K(-97.0%) |
| Sep 2012 | $440.60K | $178.40K(-334.4%) | $440.60K(-33.9%) |
| Jun 2012 | - | -$76.10K(-62.2%) | $666.60K(-47.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$201.30K(-137.3%) | $1.28M(+251.3%) |
| Dec 2011 | - | $539.60K(+33.4%) | $364.20K(-307.6%) |
| Sep 2011 | -$175.40K(-136.0%) | $404.40K(-24.7%) | -$175.40K(-66.4%) |
| Jun 2011 | - | $536.80K(-148.1%) | -$522.20K(-50.7%) |
| Mar 2011 | - | -$1.12M(<-9900.0%) | -$1.06M(-1938.5%) |
| Dec 2010 | - | $0.00(-100.0%) | $57.60K(-88.2%) |
| Sep 2010 | $487.60K(-34.0%) | $57.60K(>+9900.0%) | $487.60K(+20.0%) |
| Jun 2010 | - | $0.00(0.0%) | $406.40K(-9.0%) |
| Mar 2010 | - | $0.00(-100.0%) | $446.70K(-10.2%) |
| Dec 2009 | - | $430.00K(-1922.0%) | $497.30K(-32.7%) |
| Sep 2009 | $739.10K(-128.7%) | -$23.60K(-158.6%) | $739.20K(-107.1%) |
| Jun 2009 | - | $40.30K(-20.4%) | -$10.43M(+22.5%) |
| Mar 2009 | - | $50.60K(-92.5%) | -$8.51M(-2.7%) |
| Dec 2008 | - | $671.90K(-106.0%) | -$8.75M(+239.8%) |
| Sep 2008 | -$2.57M(-158.8%) | -$11.19M(-672.0%) | -$2.57M(-130.6%) |
| Jun 2008 | - | $1.96M(-1141.0%) | $8.42M(+39.1%) |
| Mar 2008 | - | -$187.90K(-102.7%) | $6.05M(-2.4%) |
| Dec 2007 | - | $6.85M(-3652.7%) | $6.21M(+41.7%) |
| Sep 2007 | $4.38M(-908.1%) | -$192.70K(-53.1%) | $4.38M(-76.0%) |
| Jun 2007 | - | -$410.60K(+992.0%) | $18.26M(-21.4%) |
| Mar 2007 | - | -$37.60K(-100.7%) | $23.25M(+399.4%) |
| Dec 2006 | - | $5.02M(-63.3%) | $4.66M(-958.9%) |
| Sep 2006 | -$542.00K(-123.9%) | $13.69M(+199.2%) | -$542.10K(-96.2%) |
| Jun 2006 | - | $4.58M(-124.6%) | -$14.34M(-25.0%) |
| Mar 2006 | - | -$18.63M(>+9900.0%) | -$19.12M(-970.5%) |
| Dec 2005 | - | -$177.20K(+72.7%) | $2.20M(-3.2%) |
| Sep 2005 | $2.27M(-731.1%) | -$102.60K(-50.8%) | $2.27M(+17.7%) |
| Jun 2005 | - | -$208.60K(-107.8%) | $1.93M(-13.5%) |
| Mar 2005 | - | $2.69M(-2664.7%) | $2.23M(-580.1%) |
| Dec 2004 | - | -$104.70K(-76.4%) | -$464.30K(+29.1%) |
| Sep 2004 | -$359.60K(>+9900.0%) | -$443.50K(-582.1%) | -$359.60K(-539.6%) |
| Jun 2004 | - | $92.00K(-1235.8%) | $81.80K(-902.0%) |
| Mar 2004 | - | -$8100.00(<-9900.0%) | -$10.20K(+385.7%) |
| Dec 2003 | - | $0.00(-100.0%) | -$2100.00(0.0%) |
| Sep 2003 | -$2100.00(+23.5%) | -$2100.00(<-9900.0%) | -$2100.00(<-9900.0%) |
| Jun 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2002 | - | $0.00(0.0%) | -$1700.00(0.0%) |
| Sep 2002 | -$1700.00(<-9900.0%) | $0.00(0.0%) | -$1700.00(0.0%) |
| Jun 2002 | - | $0.00(-100.0%) | -$1700.00(0.0%) |
| Mar 2002 | - | -$1700.00(<-9900.0%) | -$1700.00(<-9900.0%) |
| Dec 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2001 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2000 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2000 | -$700.00(<-9900.0%) | $0.00(0.0%) | -$700.00(0.0%) |
| Jun 2000 | - | $0.00(0.0%) | -$700.00(0.0%) |
| Mar 2000 | - | $0.00(-100.0%) | -$700.00(0.0%) |
| Dec 1999 | - | -$700.00 | -$700.00 |
| Sep 1999 | $0.00(0.0%) | - | - |
| Sep 1998 | $0.00(0.0%) | - | - |
| Sep 1997 | $0.00 | - | - |
FAQ
- What is Arrowhead Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual CFI year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly CFI year-on-year change?
- What is Arrowhead Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals TTM CFI year-on-year change?
What is Arrowhead Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of ARWR is -$420.07M
What is the all time high annual CFI for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual cash flow from investing activities is $14.12M
What is Arrowhead Pharmaceuticals annual CFI year-on-year change?
Over the past year, ARWR annual cash flow from investing activities has changed by -$323.92M (-336.87%)
What is Arrowhead Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of ARWR is -$420.21M
What is the all time high quarterly CFI for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly cash flow from investing activities is $76.91M
What is Arrowhead Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, ARWR quarterly cash flow from investing activities has changed by -$151.28M (-56.25%)
What is Arrowhead Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of ARWR is -$559.28M
What is the all time high TTM CFI for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high TTM cash flow from investing activities is $49.38M
What is Arrowhead Pharmaceuticals TTM CFI year-on-year change?
Over the past year, ARWR TTM cash flow from investing activities has changed by -$375.78M (-204.79%)